4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0000899243-19-000506
Chief Scientific Officer gave up 3,035 shares (to pay taxes)
- Chief Scientific Officer acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Erlander Mark · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-01 | Exercise or conversion : show line 1 in the form | +7,500 | 21,180 | D |
| 2019-01-01 | Shares withheld for taxes : show line 2 in the form | −3,035 | 18,145 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −7,500 | 34,688 | D |
Loading xslF345X03/doc4.xml…